A New Horizon: Oxytocin as a Novel Therapeutic Option for Obesity and Diabetes

Drug Discovery Today: Disease Mechanisms
doi 10.1016/j.ddmec.2013.05.006
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Neprilysin Inhibition: A New Therapeutic Option for Type 2 Diabetes?

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

Simvastatin and Uterine Fibroids: Opportunity for a Novel Therapeutic Option

Fertility and Sterility
GynecologyReproductive MedicineObstetrics
2018English

Exenatide (Byetta) as a Novel Treatment Option for Type 2 Diabetes Mellitus

Baylor University Medical Center Proceedings
Medicine
2006English

A Crucial Role of MafA as a Novel Therapeutic Target for Diabetes

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2005English

Leveraging MYC as a Therapeutic Treatment Option for TNBC

Oncoscience
Cancer ResearchOncology
2018English

Diabetes Mellitus as a Conformational Disease: A Novel Potential Therapeutic Approach

Endocrine Abstracts
2015English

microRNAs as a New Mechanism Regulating Adipose Tissue Inflammation in Obesity and as a Novel Therapeutic Strategy in the Metabolic Syndrome

Journal of Immunology Research
MedicineAllergyImmunology
2014English

Urinary Trypsin Inhibitor as a Therapeutic Option for Inflammatory Disorders

OA Biotechnology
2013English

The Potential of Oxytocin as a Therapeutic Target for Psychiatric Disorders

Expert Opinion on Therapeutic Targets
Molecular MedicineDrug DiscoveryClinical BiochemistryPharmacology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy